Journal: Cells
Article Title: Furin Drives Colorectal Cancer Progression and Chemoresistance Through the TGF-β/ERK Signaling Pathway
doi: 10.3390/cells15010043
Figure Lengend Snippet: Furin overexpression enhances tumor growth in vivo. ( A ) Representative images showing the gross morphology and comparative size of excised xenograft tumors from mice. Although five animals were used per group, one tumor was inadvertently damaged during excision and could not be presented as an intact representative image. Importantly, tumor volume and weight measurements were obtained from all five animals, and quantitative analyses include the full cohort. Briefly, DLD1 cells stably expressing either an empty vector or FURIN cDNA were injected subcutaneously into the right flanks of NU/J mice ( n = 5). ( B ) Tumor volume and body weight were recorded weekly to monitor growth and animal condition. ( C ) After four weeks, mice were euthanized, and the tumors were collected and weighed. Data are shown as mean ± SD ( n = 5). ( D ) Tumor lysates were analyzed by immunoblotting with antibodies against Furin, TGF-β1, pERK1/2, total ERK1/2, and GAPDH. ( E ) Immunohistochemical staining of tumor sections (5 µm) was performed using antibodies against Furin (ab183495, Abcam, 1:100), TGF-β (3C11, Santa Cruz Biotechnology, 1:2000), and pERK1/2 (137F5, Cell Signaling Technology, 1:1000). Staining was developed using the Dako EnVision+ System with 3,3′-diaminobenzidine as the chromogenic substrate. Scale bar = 200 μm. Endpoint tumor volumes and weight were compared using one-way ANOVA; * p < 0.05 was considered statistically significant.
Article Snippet: Plasmid constructs encoding human FURIN and TGF-β1 , as well as shRNAs (short hairpin RNA) targeting human FURIN and TGF-β1 , were obtained from Origene (Rockville, MD, USA).
Techniques: Over Expression, In Vivo, Stable Transfection, Expressing, Plasmid Preparation, Injection, Western Blot, Immunohistochemical staining, Staining